Tag: Antiviral
Ascletis Presented Positive Phase I Clinical Data for Broad-Spectrum Antiviral D…...
--At the dosage of 800 mg ASC10, twice daily (BID), the exposure of the active drug, ASC10-A, is comparable to that of monupiravir's...
New Data for Shionogi’s COVID-19 Once-Daily Oral Antiviral S-217622 Show Rapid...
Shionogi & Co., Ltd. (hereafter "Shionogi") today announced new results from two late-breaking presentations of S-217622 at the 32nd European Congress of Clinical...
Cambridge-based Startup CodiKoat Develops World’s Fastest COVID-Killing Antiviral Surface Protection –...
FOR IMMEDIATE RELEASE: Monday 9th August
Joshua Peacock
CodiKoat Ltd.
contact@codikoat.com
CodiKoat Develops World’s Fastest COVID-Killing Antiviral Protection
- CodiKoat are pleased to announce that our antiviral...
Innovation Pharma Announces New Brilacidin Antiviral Research on Non-SARS-CoV-2 Endemic Viral...
Presentation to be part of the “Development of New Front Line Therapies to Prevent and Treat Non-SARS-CoV-2 Endemic Viral Diseases” Breakout Session ...
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in...
SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that clinical trial start-up activities are underway...
IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication...
MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) a clinical-stage biotechnology company focused on creating...
Antiviral Drugs Market revenue to cross USD 44.5 Bn by 2027:...
Selbyville, Delaware, March 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Antiviral Drugs Market By Drug Class (DNA...